| Code | Description | Claims | Beneficiaries | Total Paid |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
28,727 |
21,736 |
$2.06M |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
4,225 |
4,225 |
$405K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
2,066 |
1,971 |
$207K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
5,008 |
4,866 |
$144K |
| 99050 |
|
1,526 |
1,469 |
$27K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
451 |
433 |
$17K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
1,248 |
1,061 |
$16K |
| 36415 |
Collection of venous blood by venipuncture |
3,299 |
3,131 |
$16K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
297 |
292 |
$11K |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
863 |
752 |
$9K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
183 |
182 |
$4K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
857 |
750 |
$1K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
46 |
45 |
$676.20 |
| 81002 |
|
46 |
43 |
$142.60 |
| 90686 |
|
21 |
21 |
$0.21 |
| 90674 |
|
56 |
56 |
$0.02 |
| 96160 |
|
87 |
87 |
$0.00 |